Şt. S. Aramă *, M. Bojincă **, Şt. Şuţeanu **, T. Negru *
* Dr. Şt. S. Aramă, şef lucrări; Prof. T. Neagu – Catedra de Fiziopatologie, U.M.F. “Carol Davila”, Bucureşti
** Dr. M. Bojincă, asistent univ; Prof. Şt. Şuţeanu – Clinica de Medicină Internă şi Reumatologie, Spitalul “Dr. I. Cantacuzino”, U.M.F. “Carol Davila” Bucureşti
Abstract
We studied the evolution of acute-phase reagents in a group of 10 patients suffering from rheumatoid vasculitis and active forms of rheumatoid arthritis. The patients received corticoid and immunosupresor treatment for at least 6 months. The favourable evolution was assessed by the decrease of ESR, CRP, fibrinogen, a1pha2 globulins percentage and rheumatoid factor level.